ATE498023T1 - Verfahren zur erkennung des fortschritts einer zervikalen dysplasie niedrigen grades - Google Patents

Verfahren zur erkennung des fortschritts einer zervikalen dysplasie niedrigen grades

Info

Publication number
ATE498023T1
ATE498023T1 AT06748239T AT06748239T ATE498023T1 AT E498023 T1 ATE498023 T1 AT E498023T1 AT 06748239 T AT06748239 T AT 06748239T AT 06748239 T AT06748239 T AT 06748239T AT E498023 T1 ATE498023 T1 AT E498023T1
Authority
AT
Austria
Prior art keywords
detecting
low grade
progress
patient
cervical dysplasia
Prior art date
Application number
AT06748239T
Other languages
English (en)
Inventor
Thomas Ried
Kerstin Heselmeyer-Haddad
Winfried Steinberg
Gert Auer
Sonia Andersson
Catharina Larsson
Original Assignee
Us Gov Health & Human Serv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Gov Health & Human Serv filed Critical Us Gov Health & Human Serv
Application granted granted Critical
Publication of ATE498023T1 publication Critical patent/ATE498023T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5755Immunoassay; Biospecific binding assay; Materials therefor for cancer of the uterine cervix, uterine corpus or endometrium
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/112Disease subtyping, staging or classification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/118Prognosis of disease development
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/36Gynecology or obstetrics
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/56Staging of a disease; Further complications associated with the disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hospice & Palliative Care (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Paper (AREA)
AT06748239T 2005-02-18 2006-02-21 Verfahren zur erkennung des fortschritts einer zervikalen dysplasie niedrigen grades ATE498023T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65417605P 2005-02-18 2005-02-18
PCT/US2006/006116 WO2006089287A2 (en) 2005-02-18 2006-02-21 Methods for detecting progression of low grade cervical dysplasia and for detecting adenocarcinomas

Publications (1)

Publication Number Publication Date
ATE498023T1 true ATE498023T1 (de) 2011-02-15

Family

ID=36778261

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06748239T ATE498023T1 (de) 2005-02-18 2006-02-21 Verfahren zur erkennung des fortschritts einer zervikalen dysplasie niedrigen grades

Country Status (10)

Country Link
US (2) US8409808B2 (de)
EP (2) EP2333117B1 (de)
JP (1) JP5053867B2 (de)
AT (1) ATE498023T1 (de)
AU (1) AU2006213996B2 (de)
CA (1) CA2598179A1 (de)
DE (1) DE602006020021D1 (de)
DK (1) DK1853735T3 (de)
ES (1) ES2360954T3 (de)
WO (1) WO2006089287A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100211066A1 (en) * 2006-06-06 2010-08-19 University Of Massachusetts Use of IMP3 as a Prognostic Marker for Cancer
US20090208965A1 (en) * 2006-10-25 2009-08-20 Ikonisys, Inc. Automated method for detecting cancers and high grade hyperplasias
KR20150090278A (ko) * 2006-10-25 2015-08-05 아이코니시스 인코포레이티드 암 또는 고등급 과형성증 세포의 자동화된 스크리닝 방법
EP2313528A4 (de) 2008-07-21 2012-01-25 Neodiagnostix Inc Verfahren für die zytologische analyse von zervixzellen
WO2011011527A2 (en) * 2009-07-21 2011-01-27 Neodiagnostix, Inc. Method and system for automated image analysis in cancer cells
WO2012033828A2 (en) * 2010-09-08 2012-03-15 Cancer Genetics, Inc. Methods for detecting human papillomavirus-associated cancers
EP3108256B1 (de) 2014-02-17 2020-06-24 Sienna Cancer Diagnostics Ltd Verfahren für den nachweis von krebs
JP6840729B2 (ja) * 2015-08-19 2021-03-10 シエナ キャンサー ダイアグノスティクス リミテッドSienna Cancer Diagnostics Ltd 癌の検出方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5756696A (en) 1986-01-16 1998-05-26 Regents Of The University Of California Compositions for chromosome-specific staining
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
AU647741B2 (en) 1989-12-01 1994-03-31 Regents Of The University Of California, The Methods and compositions for chromosome-specific staining
US5491224A (en) 1990-09-20 1996-02-13 Bittner; Michael L. Direct label transaminated DNA probe compositions for chromosome identification and methods for their manufacture
US5472842A (en) 1993-10-06 1995-12-05 The Regents Of The University Of California Detection of amplified or deleted chromosomal regions
US5830645A (en) 1994-12-09 1998-11-03 The Regents Of The University Of California Comparative fluorescence hybridization to nucleic acid arrays
US5919624A (en) 1997-01-10 1999-07-06 The United States Of America As Represented By The Department Of Health & Human Services Methods for detecting cervical cancer
US20040248107A1 (en) * 2003-06-09 2004-12-09 Sokolova Irina A. Detection of high grade dysplasia in cervical cells

Also Published As

Publication number Publication date
AU2006213996A1 (en) 2006-08-24
CA2598179A1 (en) 2006-08-24
JP5053867B2 (ja) 2012-10-24
EP2333117B1 (de) 2013-10-16
EP1853735B1 (de) 2011-02-09
US8409808B2 (en) 2013-04-02
DE602006020021D1 (de) 2011-03-24
US20140005063A1 (en) 2014-01-02
DK1853735T3 (da) 2011-05-16
EP2333117A1 (de) 2011-06-15
EP1853735A2 (de) 2007-11-14
WO2006089287A3 (en) 2006-12-14
ES2360954T3 (es) 2011-06-10
AU2006213996B2 (en) 2011-08-11
HK1115166A1 (en) 2008-11-21
WO2006089287A2 (en) 2006-08-24
US20090035763A1 (en) 2009-02-05
JP2008530998A (ja) 2008-08-14

Similar Documents

Publication Publication Date Title
ATE415175T1 (de) Ace2-aktivierung zur behandlung von herz, lungen, und nierenkrankheit und bluthochdruck
EP2121980A4 (de) Nukleinsäuresonden und verfahren zum nachweisen von plasmodium-parasiten
DE60223561D1 (de) Verfahren zum nachweis von oxidativem stress sowie kit zur durchführung davon
DE602004020327D1 (de) Verfahren zur Detektierung von Temperaturänderungen
ATE548467T1 (de) Verfahren zur identifizierung von biomarkern mit eignung bei der diagnose biologischer zustände
ATE531820T1 (de) Gesundheitszustandstest
ATE486285T1 (de) Verfahren zur früherkennung von krebs
ATE421092T1 (de) Verwendung von gfap zum nachweis von intrazerebraler blutung
EP2212700B8 (de) Verfahren zur beurteilung von kolorektalem krebs anhand einer stuhlprobe durch verwendung einer marker-kombination aus calprotectin und einem hämoglobin/haptoglobin-komplex
ATE498023T1 (de) Verfahren zur erkennung des fortschritts einer zervikalen dysplasie niedrigen grades
EP1838867A4 (de) Apolipoprotein-a-ii-isoform als biomarker für prostatakrebs
EP2062052A4 (de) Verfahren zur bestimmung einer analytkonzentration
DE602004010432D1 (de) Verfahren zur beurteilung rheumatoider arthritis durch messen von anti-ccp und interleukin 6
WO2009057294A1 (ja) 肝臓癌関連遺伝子、及び肝臓癌リスクの判定方法
ATE480642T1 (de) Verfahren zur bestimmung von genotoxizität
ATE360092T1 (de) Nukleinsäureprimer und -sonden zur detektion onkogener humaner papillomaviren
JP2007508527A5 (de)
EP1769748A4 (de) Instrument zur messung der blutgefäss-endothel-reaktion und verfahren zur steuerung des instruments zur messung der blutgefäss-endothel-reaktion
EP2650685A3 (de) Verfahren und Kit zur Klassifizierung und Prognose von Wunden
PT1721162E (pt) Método de avaliação da artrite reumatóide pela medição de anti-ccp e de amilóide a sérica
NZ599813A (en) Reagents and methods for detecting pnh type ii white blood cells and their identification as risk factors for thrombotic disorders
ATE537191T1 (de) Protein, verfahren zur proteinimmobilisierung, struktur, biosensor, nukleinsäure, vektor und kit für den nachweis einer zielsubstanz
ATE451476T1 (de) Zusammensetzungen und methoden zur bestimmung des mikrosatelliten instabilitäts (msi) status
WO2010028313A3 (en) Phosphoprotein analysis of carcinomas for assessment of drug sensitivity
WO2006012302A3 (en) Methods for rna fluorescence in situ hybridization

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties